FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018621432> ?p ?o ?g. }

• W2018621432 endingPage "667" @default.
• W2018621432 startingPage "662" @default.
• W2018621432 abstract "High mobility group box 1 (HMGB1) was recently shown to be an important extracellular mediator of severe vascular inflammatory disease, sepsis. Lysozyme (LYZ) has been shown to bind to bacterial lipopolysaccharide (LPS) and have a potential for playing a role in the therapy of inflammatory diseases. However, the effect of LYZ on HMGB1-induced septic response has not been investigated. Moreover, PEGylation effects on the antiseptic activity of LYZ are not known. Here, we show, for the first time, the anti-septic effects of PEGylated LYZ (PEG-LYZ) in HMGB1-mediated inflammatory responses in vitro and in vivo. Among four mono-PEGylated LYZs with different PEGylation sites (N-terminus, Lys(13), Lys(33), and Lys(97)), N-terminally PEGylated LYZ showed the highest activity. Subsequently, among three N-terminally PEGylated LYZs prepared with aldehyde-activated PEGs of 5, 10, and 20 kDa, 5 kDa-PEG-conjugated LYZ (P5-K(1)-LYZ) showed the highest antiseptic activity. The data showed that P5-K(1)-LYZ post-treatment effectively suppressed LPS-mediated release of HMGB1. P5-K(1)-LYZ also inhibited HMGB1-mediated hyperpermeability in human endothelial cells. Furthermore, P5-K(1)-LYZ reduced the cecal ligation and puncture (CLP)-induced release of HMGB1 and septic mortality. Collectively, these results suggest P5-K(1)-LYZ as a candidate therapeutic agent for the treatment of vascular inflammatory diseases via inhibition of the HMGB1 signaling pathway." @default.
• W2018621432 created "2016-06-24" @default.
• W2018621432 creator A5025030352 @default.
• W2018621432 creator A5025050406 @default.
• W2018621432 creator A5042655034 @default.
• W2018621432 creator A5054602576 @default.
• W2018621432 creator A5062790247 @default.
• W2018621432 creator A5075284065 @default.
• W2018621432 date "2015-04-01" @default.
• W2018621432 modified "2023-10-01" @default.
• W2018621432 title "PEGylated lysozymes with anti-septic effects in human endothelial cells and in mice" @default.
• W2018621432 cites W1629538683 @default.
• W2018621432 cites W1840042037 @default.
• W2018621432 cites W1966450685 @default.
• W2018621432 cites W1968584427 @default.
• W2018621432 cites W1973595609 @default.
• W2018621432 cites W1974952358 @default.
• W2018621432 cites W1976178426 @default.
• W2018621432 cites W1985009522 @default.
• W2018621432 cites W1989743547 @default.
• W2018621432 cites W1995227319 @default.
• W2018621432 cites W2005640704 @default.
• W2018621432 cites W2006183803 @default.
• W2018621432 cites W2016169910 @default.
• W2018621432 cites W2018653121 @default.
• W2018621432 cites W2020863075 @default.
• W2018621432 cites W2021725794 @default.
• W2018621432 cites W2022234371 @default.
• W2018621432 cites W2022871804 @default.
• W2018621432 cites W2028135479 @default.
• W2018621432 cites W2031680035 @default.
• W2018621432 cites W2034875734 @default.
• W2018621432 cites W2035433014 @default.
• W2018621432 cites W2037573601 @default.
• W2018621432 cites W2038434279 @default.
• W2018621432 cites W2047826962 @default.
• W2018621432 cites W2056809574 @default.
• W2018621432 cites W2060860123 @default.
• W2018621432 cites W2061163173 @default.
• W2018621432 cites W2082987676 @default.
• W2018621432 cites W2084587462 @default.
• W2018621432 cites W2088220499 @default.
• W2018621432 cites W2097236514 @default.
• W2018621432 cites W2117502456 @default.
• W2018621432 cites W2123949218 @default.
• W2018621432 cites W2125751904 @default.
• W2018621432 cites W2145642343 @default.
• W2018621432 cites W2159786641 @default.
• W2018621432 cites W2160196419 @default.
• W2018621432 cites W2160369507 @default.
• W2018621432 cites W2322644144 @default.
• W2018621432 cites W2783888699 @default.
• W2018621432 cites W4255628052 @default.
• W2018621432 doi "https://doi.org/10.1016/j.bbrc.2015.02.167" @default.
• W2018621432 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25769950" @default.
• W2018621432 hasPublicationYear "2015" @default.
• W2018621432 type Work @default.
• W2018621432 sameAs 2018621432 @default.
• W2018621432 citedByCount "8" @default.
• W2018621432 countsByYear W20186214322015 @default.
• W2018621432 countsByYear W20186214322017 @default.
• W2018621432 countsByYear W20186214322019 @default.
• W2018621432 countsByYear W20186214322023 @default.
• W2018621432 crossrefType "journal-article" @default.
• W2018621432 hasAuthorship W2018621432A5025030352 @default.
• W2018621432 hasAuthorship W2018621432A5025050406 @default.
• W2018621432 hasAuthorship W2018621432A5042655034 @default.
• W2018621432 hasAuthorship W2018621432A5054602576 @default.
• W2018621432 hasAuthorship W2018621432A5062790247 @default.
• W2018621432 hasAuthorship W2018621432A5075284065 @default.
• W2018621432 hasConcept C150903083 @default.
• W2018621432 hasConcept C170493617 @default.
• W2018621432 hasConcept C178790620 @default.
• W2018621432 hasConcept C185592680 @default.
• W2018621432 hasConcept C202751555 @default.
• W2018621432 hasConcept C203014093 @default.
• W2018621432 hasConcept C207001950 @default.
• W2018621432 hasConcept C2776964284 @default.
• W2018621432 hasConcept C2776966407 @default.
• W2018621432 hasConcept C2777628635 @default.
• W2018621432 hasConcept C2778384902 @default.
• W2018621432 hasConcept C2778754761 @default.
• W2018621432 hasConcept C2779149719 @default.
• W2018621432 hasConcept C2780545709 @default.
• W2018621432 hasConcept C2781460226 @default.
• W2018621432 hasConcept C55493867 @default.
• W2018621432 hasConcept C86803240 @default.
• W2018621432 hasConcept C98274493 @default.
• W2018621432 hasConceptScore W2018621432C150903083 @default.
• W2018621432 hasConceptScore W2018621432C170493617 @default.
• W2018621432 hasConceptScore W2018621432C178790620 @default.
• W2018621432 hasConceptScore W2018621432C185592680 @default.
• W2018621432 hasConceptScore W2018621432C202751555 @default.
• W2018621432 hasConceptScore W2018621432C203014093 @default.
• W2018621432 hasConceptScore W2018621432C207001950 @default.
• W2018621432 hasConceptScore W2018621432C2776964284 @default.
• W2018621432 hasConceptScore W2018621432C2776966407 @default.
• W2018621432 hasConceptScore W2018621432C2777628635 @default.

• next